CRICH MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: C81094 | MATLOCK, DE4 5PB
Showing results 101-150 of 545
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diltiazem hydrochloride | 385 | 19.3K | £2.4K | +25.4% ▲ |
| Quinine sulfate | 377 | 10.5K | £1.5K | +30.2% ▲ |
| Carbamazepine | 373 | 32.7K | £1.7K | +25.7% ▲ |
| Carbocisteine | 372 | 51.2K | £1.5K | -30.3% ▼ |
| 371 | 964 | £32.5K | -31.9% ▼ | |
| Lactulose | 362 | 229.2K | £2.1K | +10.0% ▲ |
| Estradiol | 341 | 8,551 | £4.1K | +26.4% ▲ |
| Rivaroxaban | 340 | 11.8K | £7.7K | -44.4% ▼ |
| 340 | 3,945 | £1.2K | +36.3% ▲ | |
| Mometasone furoate | 338 | 365 | £2.8K | -15.8% ▼ |
| Levetiracetam | 327 | 29.9K | £2.9K | -28.6% ▼ |
| Olanzapine | 311 | 6,614 | £991 | -16.1% ▼ |
| 311 | 320 | £462 | +41.1% ▲ | |
| Sacubitril/valsartan | 309 | 15.3K | £24.1K | +29.0% ▲ |
| Betahistine hydrochloride | 309 | 32.1K | £1.3K | +29.4% ▲ |
| Insulin aspart | 307 | 2,299 | £13.9K | -19.4% ▼ |
| 307 | 325 | £1.4K | +30.0% ▲ | |
| Dihydrocodeine tartrate | 306 | 40.9K | £2.6K | +56.6% ▲ |
| Methotrexate | 291 | 6,652 | £4.3K | -10.6% ▼ |
| Combined ethinylestradiol 30mcg | 289 | 28.2K | £1.1K | +4.1% ▲ |
| Loperamide hydrochloride | 281 | 21.3K | £814 | +20.7% ▲ |
| Buprenorphine | 280 | 1,223 | £4.8K | -23.6% ▼ |
| 273 | 58.0K | £1.6K | +3.5% ▲ | |
| Melatonin | 272 | 18.1K | £3.4K | -18.2% ▼ |
| Semaglutide | 260 | 6,930 | £23.9K | +8.0% ▲ |
| Ibuprofen | 257 | 18.8K | £487 | +110.9% ▲ |
| Aripiprazole | 253 | 6,899 | £982 | -0.6% vs avg |
| Prochlorperazine maleate | 253 | 11.2K | £725 | +25.2% ▲ |
| Glyceryl trinitrate | 252 | 459 | £649 | +6.5% ▲ |
| Mometasone furoate | 248 | 13.9K | £1.4K | +85.5% ▲ |
| Hypromellose | 245 | 3,480 | £1.1K | +84.9% ▲ |
| 244 | 19.9K | £1.4K | +12.8% ▲ | |
| Trazodone hydrochloride | 242 | 20.7K | £1.0K | +18.4% ▲ |
| Indapamide | 241 | 8,598 | £295 | -72.1% ▼ |
| Bumetanide | 239 | 11.5K | £1.1K | -12.3% ▼ |
| 238 | 46.7K | £1.0K | -49.8% ▼ | |
| Donepezil hydrochloride | 230 | 6,090 | £232 | -25.5% ▼ |
| Nifedipine | 220 | 13.1K | £1.1K | +17.4% ▲ |
| Clobetasone butyrate | 216 | 10.4K | £913 | +5.8% ▲ |
| Mebeverine hydrochloride | 215 | 20.5K | £630 | -30.8% ▼ |
| Thiamine hydrochloride | 214 | 12.2K | £300 | -59.4% ▼ |
| Clonazepam | 213 | 9,731 | £1.3K | +36.7% ▲ |
| Mirabegron | 210 | 5,535 | £5.0K | -47.7% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 209 | 16.4K | £643 | -31.8% ▼ |
| Diclofenac diethyl | 205 | 23.3K | £1.2K | -42.3% ▼ |
| Fluticasone furoate | 204 | 211 | £1.5K | +5.3% ▲ |
| Linagliptin | 201 | 6,832 | £7.6K | -50.9% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 197 | 26.4K | £1.6K | +30.3% ▲ |
| Hydroxychloroquine sulfate | 196 | 9,295 | £481 | +1.2% vs avg |
| Insulin glargine | 195 | 944 | £8.9K | -31.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.